- Fund name: Frazier Life Sciences X
- Amount raised: $617 million
- Stage of fundraising: Final close
- Final close date: Jan 2020
- Predecessor fund: Frazier Life Sciences IX (419m)
Frazier Healthcare Partners has closed its Frazier Life Sciences X fund at more than $617 million. It focuses on therapeutics-focused companies developing and commercializing bio-pharmaceuticals across North America.